Type 1 diabetes screening: need for ethical, equity, and health systems perspective.
David Beran, Aude Bandini, Emanuele Bosi, Claudia Boettcher, Marie-Anne Burckhard, Matthieu Colange, Nina Tousch, Val��rie Schwitzgebel
Author Information
- David Beran: Division of Tropical and Humanitarian Medicine, Faculty of Medicine, University of Geneva, Geneva 1211, Switzerland; Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: david.beran@unige.ch.
- Aude Bandini: Philosophy Department, University of Montreal, Montreal, QC, Canada.
- Emanuele Bosi: Diabetes Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.
- Claudia Boettcher: Pediatric Endocrinology and Diabetology, University Children's Hospital Bern, Inselspital Bern, Bern, Switzerland.
- Marie-Anne Burckhard: Pediatric Endocrinology and Diabetology, University Children's Hospital Bern, Inselspital Bern, Bern, Switzerland; Department of Clinical Research, University of Basel, Basel, Switzerland.
- Matthieu Colange: Glucose toujours, Paris, France.
- Nina Tousch: Glucose toujours, Paris, France.
- Val��rie Schwitzgebel: Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Pediatric Endocrine and Diabetes Unit, Department of Pediatrics, Obstetrics, and Gynecology, Geneva University Hospitals, Geneva, Switzerland; Institute of Genetics and Genomics (iGE3), University of Geneva, Geneva, Switzerland.
No abstract text available.
